Bluesky Facebook Reddit Email

For people with dementia with Lewy bodies, treatment with acetylcholinesterase inhibitors, with or without memantine treatment, appears to be associated with both lower risk of mortality and duration of stay for unplanned hospital admissions for physical

12.06.22 | PLOS

Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.
For people with dementia with Lewy bodies, treatment with acetylcholinesterase inhibitors, with or without memantine treatment, appears to be associated with both lower risk of mortality and duration of stay for unplanned hospital admissions for physical
Medication Credit: Peter Kindersley, Centre for Ageing Better (CC0, https://creativecommons.org/publicdomain/zero/1.0/)

In your coverage, please use this URL to provide access to the freely available paper in PLOS Medicine : http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004124

Article Title: Association between antidementia medication use and mortality in people diagnosed with dementia with Lewy bodies in the UK: A retrospective cohort study

Author Countries : United Kingdom, Belgium

Funding: see manuscript

PLOS Medicine

10.1371/journal.pmed.1004124

Observational study

People

Competing Interests: see manuscript

Keywords

Dementia Drug Therapy Health and Medicine Hospitals Pharmaceuticals

Article Information

Journal
PLOS Medicine
DOI
10.1371/journal.pmed.1004124
Method of Research
Observational study
Subject of Research
People
COI Statement
Competing Interests: see manuscript

Contact Information

Claire Turner
PLOS
medicinepress@plos.org

How to Cite This Article

APA:
PLOS. (2022, December 6). For people with dementia with Lewy bodies, treatment with acetylcholinesterase inhibitors, with or without memantine treatment, appears to be associated with both lower risk of mortality and duration of stay for unplanned hospital admissions for physical. Brightsurf News. https://www.brightsurf.com/news/1EOPMR3L/for-people-with-dementia-with-lewy-bodies-treatment-with-acetylcholinesterase-inhibitors-with-or-without-memantine-treatment-appears-to-be-associated-with-both-lower-risk-of-mortality-and-duration-of.html
MLA:
"For people with dementia with Lewy bodies, treatment with acetylcholinesterase inhibitors, with or without memantine treatment, appears to be associated with both lower risk of mortality and duration of stay for unplanned hospital admissions for physical." Brightsurf News, Dec. 6 2022, https://www.brightsurf.com/news/1EOPMR3L/for-people-with-dementia-with-lewy-bodies-treatment-with-acetylcholinesterase-inhibitors-with-or-without-memantine-treatment-appears-to-be-associated-with-both-lower-risk-of-mortality-and-duration-of.html.